Loading...

NMO WITH MOG ANTIBODY PROFILE, SERUM

image not found

NABL Cap Accredited 
The NMO with MOG Antibody Profile, Serum at Metropolis Healthcare is a specialized neurological test designed to detect antibodies associated with Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG-antibody–associated diseases. This dual-profile assessment helps differentiate between similar demyelinating conditions, ensuring accurate diagnosis. Metropolis Healthcare uses advanced immunoassay technologies to deliver reliable antibody detection. This test is recommended for individuals with optic neuritis, transverse myelitis, or unexplained neurological symptoms. Early identification supports timely treatment and better long-term neurological outcomes.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 7,500.00

Sample Type: SERUM

Fasting Not Required


Notes:N0059_Serum

Frequently Asked Questions (FAQ's):

What does the NMO with MOG Antibody Profile at Metropolis Healthcare include?
It measures AQP4-IgG and MOG-IgG antibodies to differentiate NMOSD from MOG-associated demyelinating diseases.

How does Metropolis Healthcare perform this antibody profile test?
Metropolis Healthcare uses high-sensitivity immunoassay techniques to detect specific antibodies linked to autoimmune neuro-inflammatory conditions.

Who should take this test at Metropolis Healthcare?
Individuals with optic neuritis, recurrent vision loss, transverse myelitis, or suspected autoimmune demyelinating disorders should consider this test.

Is fasting required for the NMO with MOG Antibody Profile at Metropolis Healthcare?
No, fasting is not required; a simple blood sample is adequate.

How long do results take at Metropolis Healthcare?
Results are usually available within 5–7 days due to the specialized nature of antibody testing.

Can this test at Metropolis Healthcare confirm NMOSD or MOG-related disease?
A positive antibody result strongly supports diagnosis, but clinical evaluation and imaging are also essential.

How accurate is this combined antibody profile at Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy using validated immunoassay platforms and rigorous quality protocols.

Can this test help guide treatment decisions at Metropolis Healthcare?
Yes, identifying AQP4-IgG or MOG-IgG helps clinicians select appropriate immunotherapy and plan long-term neurological care.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab